On Nov 2, 2021 Cambridge Epigenetix closed a Series D round and raised $88,000,000 from Ahren Innovation Capital, GV, New Science Ventures, Sequoia Capital, Temasek […]
Series B – Violet Defense
On Nov 2, 2021 Violet Defense closed a Series B round and raised $20,000,000 from Katalyst Securities, Kirenaga Partners, featuring lead investors Katalyst Securities, Kirenaga […]
Series C – Lightforce Orthodontics
On Nov 2, 2021 Lightforce Orthodontics closed a Series C round and raised $50,000,000 from AM Ventures, Kleiner Perkins, Matrix Partners, Tyche Partners, featuring lead […]
Venture Round – Shoreline Biosciences
On Nov 2, 2021 Shoreline Biosciences closed a Venture – Series Unknown round and raised $140,000,000 from Ally Bridge Group, BeiGene, Boxer Capital, BVF Partners, […]
SimplePay Health acquired by Coupe Health
Nov 1, 2021 Coupe Health has entered into an agreement to acquire SimplePay Health . Coupe Health based at Eagan, Minnesota, United States. ” Health […]
Delta Health Technologies acquired by AlayaCare
Nov 1, 2021 AlayaCare has entered into an agreement to acquire Delta Health Technologies . AlayaCare based at Montréal, Quebec, Canada. “AlayaCare is a revolutionary […]
Health Partners Plans acquired by Jefferson Health System
Nov 1, 2021 Jefferson Health System has entered into an agreement to acquire Health Partners Plans in a $305,000,000 deal. Jefferson Health System based at […]
Grant – InterveXion Therapeutics
On Nov 1, 2021 InterveXion Therapeutics closed a Grant round and raised $13,800,000 from National Institutes of Health, featuring lead investors National Institutes of Health. […]
Post-IPO Equity – Valneva
On Nov 1, 2021 Valneva closed a Post-IPO Equity round and raised €88,000,000 from investors, featuring lead investors . About the company: Valneva is located […]
Post-IPO Equity – NovaBay Pharmaceuticals
On Nov 1, 2021 NovaBay Pharmaceuticals closed a Post-IPO Equity round and raised $15,000,000 from investors, featuring lead investors . About the company: NovaBay Pharmaceuticals […]
